US equities
|
NVDA
$241.71
▲+1.18%
SPCX
$174.30
▲+1.88%
MU
$1,058.35
▼-0.53%
AMD
$630.02
▼-0.27%
MRVL
$287.91
▲+6.14%
META
$744.42
▲+0.34%
TSLA
$383.06
▲+1.14%
SNDK
$1,687.12
▼-1.00%
NVDA
$241.71
▲+1.18%
SPCX
$174.30
▲+1.88%
MU
$1,058.35
▼-0.53%
AMD
$630.02
▼-0.27%
MRVL
$287.91
▲+6.14%
META
$744.42
▲+0.34%
TSLA
$383.06
▲+1.14%
SNDK
$1,687.12
▼-1.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Tzield
Recent news which mentions Tzield
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Tickers
AMGN
CHRS
CYTK
IBB
Tags
Penny Stocks
Tzield
ZLAB
From
Benzinga